术中应用右美托咪定降低新生儿和婴儿先天性心脏病术后快速性心律失常发生率的效果:双稳健方法估计分析
该研究基于欧洲先天性心脏病外科协会数据库2017—2021年593例手术(514例患者),采用双稳健匹配估计分析术中应用高剂量右美托咪定(1-1.4 µg/kg/h)对术后快速性心律失常的影响。匹配后426例手术(每组213例)中,暴露组术后快速性心律失常概率为6.6%(95%CI 0.032-0.099),非暴露组为14.5%(95%CI 0.098-0.193),双稳健匹配估计显示平均降低8.8%(95%CI -0.137至-0.023)。结论认为术中应用高剂量右美托咪定与术后快速性心律失常中度但显著的降低相关。
要点
- 术中应用高剂量右美托咪定(1-1.4 µg/kg/h)与新生儿和婴儿先天性心脏病术后快速性心律失常中度但显著的降低相关。
- 匹配后暴露组术后快速性心律失常概率为6.6%(95%CI 0.032-0.099),非暴露组为14.5%(95%CI 0.098-0.193)。
- 双稳健匹配估计显示术后快速性心律失常平均降低8.8%(95%CI -0.137至-0.023)。
核心结论
- 新生儿和婴儿先天性心脏病手术麻醉期间使用高剂量右美托咪定与术后快速性心律失常中度但显著的降低相关。
研究设计与样本
- 基于欧洲先天性心脏病外科协会数据库的5年期间(2017—2021年)数据,纳入在体外循环下接受先天性心脏病手术的患者,期间实施了术中高剂量右美托咪定(1-1.4 µg/kg/h)的应用。
- 对右美托咪定与术后快速性心律失常发生率的因果效应进行双稳健匹配估计,结合未暴露患者的疾病风险评分多模态估计模型和暴露患者的匹配队列回归分析。
- 研究期间共593例手术(514例患者),双匹配分析包括426例在右美托咪定下或未在右美托咪定下进行的手术(每组213例)。
主要发现
- 暴露于右美托咪定的患者发生术后快速性心律失常的概率为6.6%(95%置信区间0.032-0.099),未暴露组为14.5%(95%置信区间0.098-0.193)。
- 双稳健匹配估计方法显示,术中麻醉使用右美托咪定时术后快速性心律失常平均降低8.8%(95%置信区间-0.137至-0.023)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The antiarrhythmic effects of dexmedetomidine (DEX) have been suggested, but there are controversial reports on the effectiveness of intraoperative use of DEX to reduce the incidence of postoperative tachyarrhythmia (POT). METHODS: From a local European Congenital Heart Surgery Association database, we included patients operated for congenital heart diseases under cardiopulmonary bypass within a 5-year period (2017-2021), during which intraoperative use of high dose of DEX (1-1.4 µg/kg/h) was implemented. A doubly robust matching estimation of the causal effect of DEX on the incidence of POT was conducted. We combined a multimodal estimation model in patients not exposed to DEX (disease risk score) as well as a regression analysis in a matched cohort for patients exposured to DEX. RESULTS: From a cohort of 593 surgeries (514 patients) occurring during the study period, doubly matched analysis consisted of the analysis of 426 surgeries conducted under DEX or not (213 per group). The probability of developing POT in patients exposed to DEX was 6.6% (95% confidence interval 0.032-0.099) vs 14.5% (95% confidence interval 0.098-0.193) in the group of patients not exposed to DEX. The doubly robust matched estimation method showed a mean reduction of 8.8% (95% confidence interval -0.137 to -0.023) of POT when DEX is used for intraoperative anaesthesia. CONCLUSIONS: The use of high doses of DEX during anaesthesia for congenital heart surgery in neonates and infants is associated with a moderate but significant reduction of POT.
引用
- Bourgoin P, Jegard J, Joram N, et al. Effectiveness of intraoperative use of dexmedetomidine in reducing the incidence of tachyarrhythmia after congenital cardiac surgery in neonates and infants: a doubly robust method estimation analysis. Eur J Cardiothorac Surg. 2023. PMID: 36864617. doi:10.1093/ejcts/ezad076
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。